Cleared Traditional

K023656 - SICKLE-CHEX SOLUBILITY KIT

K023656 is the FDA 510(k) clearance for SICKLE-CHEX SOLUBILITY KIT by Streck Laboratories, Inc.. It is a Class 2 Hematology device (product code GHM) cleared through the Traditional 510(k) pathway after a 61-day FDA review.

K023656 · Streck Laboratories, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
61d
Days
Class 2
Risk

K023656 is an FDA 510(k) clearance for the SICKLE-CHEX SOLUBILITY KIT. Classified as Test, Sickle Cell (product code GHM), Class II - Special Controls.

Submitted by Streck Laboratories, Inc. (La Vista, US). The FDA issued a Cleared decision on December 30, 2002 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7825 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Streck Laboratories, Inc. devices

Submission Details

510(k) Number K023656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 2002
Decision Date December 30, 2002
Days to Decision 61 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 113d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GHM Test, Sickle Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7825
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GHM Test, Sickle Cell

All 8
Devices cleared under the same product code (GHM) and FDA review panel - the closest regulatory comparables to K023656.
SICKLE-CHEX
K013316 · Streck Laboratories, Inc. · Nov 2001
SAS SICKLE CELL TEST
K960947 · Sa Scientific, Inc. · Jul 1996
HEMOCARD HEMOGLOBIN S
K911981 · Isolab, Inc. · Oct 1991
HEMOCARD-AS
K910430 · Isolab, Inc. · Apr 1991
SICKLE CELL REAGENT SET
K860420 · Sterling Diagnostics, Inc. · Feb 1986
SICKLING HEMOGLOBIN CONTROLS, NORMAL
K842152 · Isolab, Inc. · Sep 1984